BIIB News
Biogen Inc.
$252.26
+$1.57(+0.63%)
75
Overall
80
Value
100
Tech
47
Quality
Market Cap
$37.51B
Volume
958.80K
52W Range
$138.00 - $254.41
Target Price
$242.94
BIIB news: the latest Biogen Inc. headlines, press releases and market updates, newest first.
Latest BIIB News
- Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB), Elevance Health (ELV) and Myriad Genetics (MYGN)TipRanks Newsroom · Oct 22, 2026
- Wells Fargo Reaffirms Their Buy Rating on Biogen (BIIB)TipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
- Wells Fargo Reaffirms Their Buy Rating on Biogen (BIIB)TipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
- Biogen’s BIIB147 ALS Trial: A Long-Horizon Catalyst for Neurology InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 19, 2026
- OCUL, IDXX, BIIB, BFLY, TMUS Trending With AnalystsTipRanks Weekend Auto-Generated Newsdesk · Oct 17, 2026
- Wells Fargo Sticks to Their Buy Rating for Biogen (BIIB)TipRanks Auto-Generated Intelligence Newsdesk · Oct 15, 2026
- Piper Sandler Keeps Their Buy Rating on Biogen (BIIB)TipRanks Auto-Generated Intelligence Newsdesk · Oct 12, 2026
- AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?Ran Melamed · Oct 7, 2026
- Piper Sandler Keeps Their Buy Rating on Biogen (BIIB)TipRanks Auto-Generated Intelligence Newsdesk · Oct 5, 2026
- Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO) and Biogen (BIIB)TipRanks Newsroom · Oct 2, 2026
- Biogen’s Salanersen Trial Strengthens Its SMA Pipeline OutlookTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 2, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BIIB | $252.26 | +0.6% | 958.80K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |